| Regulating Pair |
| Introduced Variation |
Inhibition (BI01383298) of SLC13A2 |
Protein Info
|
| Induced Change |
Citric acid concentration: decrease (FC = 0.40) |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of citric acid concentration after SLC13A2 inhibition through kit detection |
| Disease Status |
Healthy individual |
| Organ/Tissue/Cell Line |
HepG2 cells (Human hepatoma cells) |
Liver |
| Subcellular Location |
Membrane |
| Tested Species |
Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
|
| Details |
It is reported that inhibition of SLC13A2 leads to the decrease of citric acid levels compared with control group in HepG2 cells. |
|
|
|
|
|
|
|
| References |
| 1 |
Functional analysis of a species-specific inhibitor selective for human Na+-coupled citrate transporter (NaCT/SLC13A5/mINDY). Biochem J. 2020 Nov 13;477(21):4149-4165.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
